Joe Rancour represents clients in connection with antitrust aspects of mergers and acquisitions and antitrust litigation. Mr. Rancour has experience across a variety of industries, including semiconductors and other high technology markets, telecommunications, medical devices, life sciences, chemicals, and financial exchanges.

Examples of Mr. Rancour’s M&A representations include:

  • Sprint in its proposed merger with T-Mobile;
  • CME Group in its acquisition of NEX;
  • Intel in its acquisition of Mobileye, sale of Wind River to TPG and spin-out of the Intel Security business (McAfee);
  • NXP in its proposed acquisition by Qualcomm;
  • Cardinal Health in its acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses;
  • Nokia in its acquisition of Alcatel-Lucent;
  • Freescale in its acquisition by NXP;
  • Merck KGaA in its acquisition of Sigma-Aldrich; and
  • Corning in its acquisition of Becton Dickinson’s Discovery Labware.

Examples of Mr. Rancour’s litigation representations include:

  • Sprint in its challenge to AT&T’s proposed acquisition of T-Mobile; and
  • Norfolk Southern Railway Co. in a multi-defendant antitrust class action.

Mr. Rancour also has represented clients in pro bono matters, including Social Security disability and estate planning.



  • J.D., Cornell Law School, 2010 (magna cum laude; Order of the Coif)
  • B.A., University of Michigan, 2007 (With High Distinction; Phi Beta Kappa)


  • District of Columbia

Joseph M. Rancour